Filing Details
- Accession Number:
- 0001140361-22-045162
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-09 21:30:36
- Reporting Period:
- 2022-12-08
- Accepted Time:
- 2022-12-09 21:30:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1635088 | Roivant Sciences Ltd. | ROIV | Pharmaceutical Preparations (2834) | 981173944 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1801917 | Eric Venker | C/O Roivant Sciences Ltd. 7Th Floor, 50 Broadway London X0 SW1H 0DB | President & Coo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Disposition | 2022-12-08 | 11,729 | $7.00 | 1,022,118 | No | 4 | S | Direct | |
Common Shares | Disposition | 2022-12-09 | 133,376 | $7.03 | 888,742 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022.